vs
Pennant Group, Inc.（PNTG）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
Pennant Group, Inc.的季度营收约是STURM RUGER & CO INC的1.9倍（$289.3M vs $151.1M），Pennant Group, Inc.同比增速更快（53.2% vs 3.6%），Pennant Group, Inc.自由现金流更多（$17.4M vs $12.3M），过去两年Pennant Group, Inc.的营收复合增速更高（35.8% vs 5.1%）
Pennant Group, Inc.是一家总部位于美国的医疗服务企业，主营家庭健康护理、临终关怀、长者居住服务及专业护理服务，业务覆盖美国数十个州，核心服务对象为老年及有特殊医疗需求的弱势人群。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
PNTG vs RGR — 直观对比
营收规模更大
PNTG
是对方的1.9倍
$151.1M
营收增速更快
PNTG
高出49.5%
3.6%
自由现金流更多
PNTG
多$5.1M
$12.3M
两年增速更快
PNTG
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $289.3M | $151.1M |
| 净利润 | $8.6M | — |
| 毛利率 | — | 17.8% |
| 营业利润率 | 6.0% | 2.3% |
| 净利率 | 3.0% | — |
| 营收同比 | 53.2% | 3.6% |
| 净利润同比 | 50.0% | — |
| 每股收益（稀释后） | $0.25 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PNTGRGR
| Q4 25 | $289.3M | $151.1M | ||
| Q3 25 | $229.0M | $126.8M | ||
| Q2 25 | $219.5M | $132.5M | ||
| Q1 25 | $209.8M | $135.7M | ||
| Q4 24 | $188.9M | $145.8M | ||
| Q3 24 | $180.7M | $122.3M | ||
| Q2 24 | $168.7M | $130.8M | ||
| Q1 24 | $156.9M | $136.8M |
净利润PNTGRGR
| Q4 25 | $8.6M | — | ||
| Q3 25 | $6.1M | $1.6M | ||
| Q2 25 | $7.1M | $-17.2M | ||
| Q1 25 | $7.8M | $7.8M | ||
| Q4 24 | $5.8M | — | ||
| Q3 24 | $6.2M | $4.7M | ||
| Q2 24 | $5.7M | $8.3M | ||
| Q1 24 | $4.9M | $7.1M |
毛利率PNTGRGR
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | 15.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 22.8% | ||
| Q3 24 | — | 18.5% | ||
| Q2 24 | — | 22.3% | ||
| Q1 24 | — | 21.5% |
营业利润率PNTGRGR
| Q4 25 | 6.0% | 2.3% | ||
| Q3 25 | 4.5% | -2.7% | ||
| Q2 25 | 5.3% | -15.6% | ||
| Q1 25 | 6.0% | 6.2% | ||
| Q4 24 | 4.9% | 7.8% | ||
| Q3 24 | 6.0% | 3.1% | ||
| Q2 24 | 5.7% | 6.9% | ||
| Q1 24 | 5.4% | 5.5% |
净利率PNTGRGR
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.7% | 1.2% | ||
| Q2 25 | 3.2% | -13.0% | ||
| Q1 25 | 3.7% | 5.7% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 3.4% | 3.9% | ||
| Q2 24 | 3.4% | 6.3% | ||
| Q1 24 | 3.1% | 5.2% |
每股收益（稀释后）PNTGRGR
| Q4 25 | $0.25 | $0.22 | ||
| Q3 25 | $0.17 | $0.10 | ||
| Q2 25 | $0.20 | $-1.05 | ||
| Q1 25 | $0.22 | $0.46 | ||
| Q4 24 | $0.16 | $0.62 | ||
| Q3 24 | $0.20 | $0.28 | ||
| Q2 24 | $0.18 | $0.47 | ||
| Q1 24 | $0.16 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $92.5M |
| 总债务越低越好 | $168.8M | — |
| 股东权益账面价值 | $374.3M | $283.8M |
| 总资产 | $968.2M | $342.0M |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资PNTGRGR
| Q4 25 | — | $92.5M | ||
| Q3 25 | — | $80.8M | ||
| Q2 25 | — | $101.4M | ||
| Q1 25 | — | $108.3M | ||
| Q4 24 | — | $105.5M | ||
| Q3 24 | — | $96.0M | ||
| Q2 24 | — | $105.6M | ||
| Q1 24 | — | $115.3M |
总债务PNTGRGR
| Q4 25 | $168.8M | — | ||
| Q3 25 | $26.0M | — | ||
| Q2 25 | $37.0M | — | ||
| Q1 25 | $52.5M | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $108.9M | — | ||
| Q2 24 | $82.2M | — | ||
| Q1 24 | $83.3M | — |
股东权益PNTGRGR
| Q4 25 | $374.3M | $283.8M | ||
| Q3 25 | $343.0M | $279.6M | ||
| Q2 25 | $333.6M | $289.3M | ||
| Q1 25 | $323.0M | $321.5M | ||
| Q4 24 | $312.0M | $319.6M | ||
| Q3 24 | $187.3M | $314.9M | ||
| Q2 24 | $173.0M | $321.5M | ||
| Q1 24 | $164.2M | $332.0M |
总资产PNTGRGR
| Q4 25 | $968.2M | $342.0M | ||
| Q3 25 | $753.6M | $342.3M | ||
| Q2 25 | $751.4M | $349.5M | ||
| Q1 25 | $743.6M | $379.0M | ||
| Q4 24 | $679.5M | $384.0M | ||
| Q3 24 | $646.8M | $373.5M | ||
| Q2 24 | $602.5M | $376.7M | ||
| Q1 24 | $578.2M | $385.0M |
负债/权益比PNTGRGR
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.08× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $17.4M | $12.3M |
| 自由现金流率自由现金流/营收 | 6.0% | 8.2% |
| 资本支出强度资本支出/营收 | 1.2% | 2.1% |
| 现金转化率经营现金流/净利润 | 2.43× | — |
| 过去12个月自由现金流最近4个季度 | $36.3M | $38.5M |
8季度趋势，按日历期对齐
经营现金流PNTGRGR
| Q4 25 | $21.0M | $15.5M | ||
| Q3 25 | $13.9M | $12.9M | ||
| Q2 25 | $34.6M | $14.7M | ||
| Q1 25 | $-21.2M | $11.1M | ||
| Q4 24 | $20.6M | $20.0M | ||
| Q3 24 | $7.7M | $9.4M | ||
| Q2 24 | $10.5M | $18.7M | ||
| Q1 24 | $545.0K | $7.3M |
自由现金流PNTGRGR
| Q4 25 | $17.4M | $12.3M | ||
| Q3 25 | $10.5M | $7.0M | ||
| Q2 25 | $31.6M | $9.1M | ||
| Q1 25 | $-23.2M | $10.0M | ||
| Q4 24 | $17.2M | $16.4M | ||
| Q3 24 | $6.8M | $2.6M | ||
| Q2 24 | $8.9M | $10.1M | ||
| Q1 24 | $-2.6M | $5.6M |
自由现金流率PNTGRGR
| Q4 25 | 6.0% | 8.2% | ||
| Q3 25 | 4.6% | 5.5% | ||
| Q2 25 | 14.4% | 6.9% | ||
| Q1 25 | -11.1% | 7.4% | ||
| Q4 24 | 9.1% | 11.2% | ||
| Q3 24 | 3.8% | 2.1% | ||
| Q2 24 | 5.3% | 7.7% | ||
| Q1 24 | -1.7% | 4.1% |
资本支出强度PNTGRGR
| Q4 25 | 1.2% | 2.1% | ||
| Q3 25 | 1.5% | 4.6% | ||
| Q2 25 | 1.4% | 4.2% | ||
| Q1 25 | 0.9% | 0.8% | ||
| Q4 24 | 1.8% | 2.5% | ||
| Q3 24 | 0.5% | 5.5% | ||
| Q2 24 | 1.0% | 6.6% | ||
| Q1 24 | 2.0% | 1.3% |
现金转化率PNTGRGR
| Q4 25 | 2.43× | — | ||
| Q3 25 | 2.29× | 8.15× | ||
| Q2 25 | 4.89× | — | ||
| Q1 25 | -2.73× | 1.43× | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | 1.24× | 1.98× | ||
| Q2 24 | 1.84× | 2.27× | ||
| Q1 24 | 0.11× | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
